MT Newswires
Wall Street Set to Open Little Changed as Investors Await Home Sales, Consumer Sentiment Data
➖
AI Sentiment
Neutral
5/10
- Home
- NBY
as of 12-24-2025 10:38am EST
$4.89
+$0.32
+7.00%
Stocks Nasdaq
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.
| Founded: | 2000 | Country: | United States |
| Employees: | N/A | City: | EMERYVILLE |
| Market Cap: | 398.2M | IPO Year: | 2007 |
| Target Price: | N/A | AVG Volume (30 days): | 2.3M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.47 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.46 - $6.47 | Next Earning Date: | 11-07-2025 |
| Revenue: | $10,302,000 | Revenue Growth: | 390.34% |
| Revenue Growth (this year): | 23.91% | Revenue Growth (next year): | 32.05% |
Latest NovaBay Pharmaceuticals Inc. News
NBY Breaking Stock News: Dive into NBY Ticker-Specific Updates for Smart Investing
Compare NBY vs Leading Stocks
See how NBY stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "NBY NovaBay Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.